BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 21928635)

  • 21. Emptying the rectum before treatment delivery limits the variations of rectal dose - volume parameters during 3DCRT of prostate cancer.
    Stasi M; Munoz F; Fiorino C; Pasquino M; Baiotto B; Marini P; Malinverni G; Valdagni R; Gabriele P
    Radiother Oncol; 2006 Sep; 80(3):363-70. PubMed ID: 16959344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A digital male pelvis phantom series showing anatomical variations over the course of fractionated radiotherapy treatment.
    Faddegon B; Descovich M; Chen K; Ramos-Méndez J; Iii MR; Wahl N; Taylor P; Griffin K; Lee C
    Med Phys; 2024 Apr; 51(4):3034-3044. PubMed ID: 38071746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosimetric feasibility of moderately hypofractionated/dose escalated radiation therapy for localised prostate cancer with intensity-modulated proton beam therapy using simultaneous integrated boost (SIB-IMPT) and impact of hydrogel prostate-rectum spacer.
    Ahmad Khalil D; Jazmati D; Geismar D; Wulff J; Bäumer C; Kramer PH; Steinmeier T; Schulze Schleitthoff S; Plaude S; Bischoff M; Tschirdewahn S; Hadaschik B; Timmermann B
    Radiat Oncol; 2022 Apr; 17(1):64. PubMed ID: 35365170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ion therapy of prostate cancer: daily rectal dose reduction by application of spacer gel.
    Rucinski A; Brons S; Richter D; Habl G; Debus J; Bert C; Haberer T; Jäkel O
    Radiat Oncol; 2015 Feb; 10():56. PubMed ID: 25886457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation of rectal dose using daily megavoltage cone-beam computed tomography and deformable image registration.
    Akino Y; Yoshioka Y; Fukuda S; Maruoka S; Takahashi Y; Yagi M; Mizuno H; Isohashi F; Ogawa K
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):602-8. PubMed ID: 24074934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer.
    Chera BS; Vargas C; Morris CG; Louis D; Flampouri S; Yeung D; Duvvuri S; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):994-1002. PubMed ID: 19619961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles.
    Rana S; Cheng C; Zhao L; Park S; Larson G; Vargas C; Dunn M; Zheng Y
    J Med Radiat Sci; 2017 Mar; 64(1):18-24. PubMed ID: 27741379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting rectal and bladder overdose during the course of prostate radiotherapy using dose-volume data from initial treatment fractions.
    Murthy V; Shukla P; Adurkar P; Master Z; Mahantshetty U; Shrivastava S
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):119-24. PubMed ID: 22300567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the Influence of Peripheral Anatomical Changes for CBCT-Guided Prostate Cancer Radiotherapy.
    Zhang Y; Zhang X; Li J; Zeng L; Wang X; Wu X; Li Y; Li X; Zhong R
    Technol Cancer Res Treat; 2021; 20():15330338211016370. PubMed ID: 33982618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Daily CT localization for correcting portal errors in the treatment of prostate cancer.
    Lattanzi J; McNeely S; Hanlon A; Das I; Schultheiss TE; Hanks GE
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1079-86. PubMed ID: 9719118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IMRT to escalate the dose to the prostate while treating the pelvic nodes.
    Cavey ML; Bayouth JE; Colman M; Endres EJ; Sanguineti G
    Strahlenther Onkol; 2005 Jul; 181(7):431-41. PubMed ID: 15995836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
    Qin A; Sun Y; Liang J; Yan D
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosimetric uncertainty in prostate cancer proton radiotherapy.
    Lin L; Vargas C; Hsi W; Indelicato D; Slopsema R; Li Z; Yeung D; Horne D; Palta J
    Med Phys; 2008 Nov; 35(11):4800-7. PubMed ID: 19070212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
    Chapman CH; Polan D; Vineberg K; Jolly S; Maturen KE; Brock KK; Prisciandaro JI
    Brachytherapy; 2018; 17(2):360-367. PubMed ID: 29331573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy.
    O'Daniel JC; Dong L; Zhang L; de Crevoisier R; Wang H; Lee AK; Cheung R; Tucker SL; Kudchadker RJ; Bonnen MD; Cox JD; Mohan R; Kuban DA
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):883-91. PubMed ID: 17011461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison.
    De Meerleer GO; Vakaet LA; De Gersem WR; De Wagter C; De Naeyer B; De Neve W
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):639-48. PubMed ID: 10837946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
    Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of intrafraction and residual interfraction effect on prostate proton pencil beam scanning.
    Tang S; Deville C; Tochner Z; Wang KK; McDonough J; Vapiwala N; Both S
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1186-94. PubMed ID: 25442043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy.
    Devlin L; Dodds D; Sadozye A; McLoone P; MacLeod N; Lamb C; Currie S; Thomson S; Duffton A
    Br J Radiol; 2020 Apr; 93(1108):20190789. PubMed ID: 31971829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.
    Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.